Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.

作者: Riccardo Asero

DOI:

关键词:

摘要: Summary Background. Some patients seem to show a particular propensity experience systemic reactions (SR) when undergoing SCIT. This study looked at their features. Methods. 423 adults submitted subcutaneous immunotherapy (SCIT) with 583 depot allergens extracts were studied. A “slow” build-up schedule was followed, and maintenance doses given monthly. No mixtures of employed; multi-sensitized treated two the same time. IgE pollen allergen components measured. Patients experiencing several SR those showing repeated large local preventing up dosing analyzed. Results. Altogether, 14% experienced least 2 SCIT further 13% reactions. All involved skin. Eight treatments stopped. reactor using beta-blockers. not associated season, use freshly prepared vials, administration allergens, or extract producer, nor preceded by Reactors younger than tolerant subjects (p < 0.05), females less frequently fully males 0.001). The multiple regression analysis showed that both ragweed grass significantly adverse Specific Amb 1 Phl p did differ statistically between reactors subjects, whereas pollen-allergic higher levels 5. Intolerance depend on number primary sensitizations hypersensitivity pan-allergens. Conclusion. Young women hypersensitive risk for during

参考文章(21)
T. Zuberbier, M. Balke, M. Worm, G. Edenharter, M. Maurer, Epidemiology of urticaria: a representative cross-sectional population survey. Clinical and Experimental Dermatology. ,vol. 35, pp. 869- 873 ,(2010) , 10.1111/J.1365-2230.2010.03840.X
Ozlem Goksel, Omur Aydın, Cetin Atasoy, Serdar Akyar, Yavuz Selim Demirel, Zeynep Misirligil, Sevim Bavbek, Hypersensitivity Reactions to Contrast Media: Prevalence, Risk Factors and the Role of Skin Tests in Diagnosis – A Cross-Sectional Survey International Archives of Allergy and Immunology. ,vol. 155, pp. 297- 305 ,(2011) , 10.1159/000320760
Matthew A. Rank, David I. Bernstein, Improving the Safety of Immunotherapy The Journal of Allergy and Clinical Immunology: In Practice. ,vol. 2, pp. 131- 135 ,(2014) , 10.1016/J.JAIP.2013.09.017
Lisha Jenny John, Sharfaa Ahmed, Fiza Anjum, Mohieddin Kebab, Naik Mohammed, Haitham Darwich, Nusaibah Ibraheem, Mohamed Arifulla, Jayadevan Sreedharan, Prevalence of Allergies among University Students: A Study from Ajman, United Arab Emirates International Scholarly Research Notices. ,vol. 2014, pp. 502052- 502052 ,(2014) , 10.1155/2014/502052
M. T. Mellerup, G. W. Hahn, L. K. Poulsen, H.-J. Malling, Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clinical & Experimental Allergy. ,vol. 30, pp. 1423- 1429 ,(2000) , 10.1046/J.1365-2222.2000.00910.X
Riccardo Asero, Emanuele Bellotto, Alessandra Ghiani, Roberta Aina, Danilo Villalta, Sandra Citterio, Concomitant sensitization to ragweed and mugwort pollen: who is who in clinical allergy? Annals of Allergy Asthma & Immunology. ,vol. 113, pp. 307- 313 ,(2014) , 10.1016/J.ANAI.2014.06.009
H AMIN, G LISS, D BERNSTEIN, Evaluation of near-fatal reactions to allergen immunotherapy injections The Journal of Allergy and Clinical Immunology. ,vol. 117, pp. 169- 175 ,(2006) , 10.1016/J.JACI.2005.10.010
Jean Bousquet, Richard Lockey, Hans-Jorgen Malling, None, Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper The Journal of Allergy and Clinical Immunology. ,vol. 102, pp. 558- 562 ,(1998) , 10.1016/S0091-6749(98)70271-4
Christopher W. Calabria, Adrienne Stolfi, Michael S. Tankersley, The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions Annals of Allergy Asthma & Immunology. ,vol. 106, pp. 49- 53 ,(2011) , 10.1016/J.ANAI.2010.10.025
C. Moreno, J. Cuesta-Herranz, L. Fernandez-Tavora, E. Alvarez-Cuesta, , Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases Clinical & Experimental Allergy. ,vol. 34, pp. 527- 531 ,(2004) , 10.1111/J.1365-2222.2004.1819.X